MYO6 and neoplasm: The finding that overexpression of ZNF191 significantly down-regulated BMPR2, PDGFR and MYO6, whereas silencing of ZNF191 increased BMPR2, PDGFR and MYO6 expression suggests a tumor suppressor role for ZNF191 in human cancers.